Related Experiment Video

Updated: Aug 9, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

DNA-binding independent cell death from a minimal proapoptotic region of E2F-1

L A Bell1, J O'Prey, K M Ryan

  • 1Tumour Cell Death Laboratory, Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Garscube Estate, Glasgow, UK.

Oncogene
|May 3, 2006
PubMed

Insights

Cancer cells evade death by progressing through the cell cycle. Researchers identified a small E2F-1 protein domain that induces cancer cell death independently of DNA binding, offering new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Death Mechanisms

Background:

  • Cancer cells evade apoptosis, a key hallmark of cancer, often through deregulation of transcription factors like E2F.
  • While E2F's role in cell cycle progression is understood, its mechanisms for inducing apoptosis are less clear.
  • Existing models suggest E2F-induced apoptosis involves target gene regulation, but some E2F mutants lacking transactivation domains still trigger cell death.

Purpose of the Study:

  • To investigate the mechanisms by which E2F induces apoptosis independent of its transactivation function.
  • To identify the minimal domain within E2F responsible for inducing cell death.
  • To explore the therapeutic potential of this novel cell death-inducing mechanism in cancer.

Main Methods:

  • Creation and analysis of transactivation-independent E2F-1 mutants.
  • Refinement of mutants to pinpoint a minimal apoptotic domain.
  • Assessment of DNA-binding activity and transactivation/repression capabilities of the identified domain.
  • Comparative analysis of homologous domains in E2F-2 and E2F-3.

Main Results:

  • A 75-amino acid region within the DNA-binding domain of E2F-1 was sufficient to induce cell death.
  • This cell death-inducing activity was conserved in the homologous domains of E2F-2 and E2F-3.
  • Crucially, this minimal E2F-1 domain did not bind DNA, negating its known transcriptional roles.

Conclusions:

  • E2F proteins possess a novel, DNA-binding-independent mechanism for inducing apoptosis.
  • This finding challenges current understanding of E2F function and its role in cancer.
  • Targeting this non-transcriptional apoptotic function of E2F presents a promising new avenue for cancer therapy.

More Related Videos

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...